Man Li1, Yue Li2, Long Zuo3, Wenli Hu2, Tao Jiang3. 1. Radiology Department, Beijing Chao-Yang Hospital, Capital Medical University, No. 8, South Gongti Road, Chaoyang District, Beijing, 100020, P.R. China. pkumanli@163.com. 2. Neurology Department, Beijing Chao-Yang Hospital, Capital Medical University, No. 8, South Gongti Road, Chaoyang District, Beijing, P.R. China. 3. Radiology Department, Beijing Chao-Yang Hospital, Capital Medical University, No. 8, South Gongti Road, Chaoyang District, Beijing, 100020, P.R. China.
Abstract
BACKGROUND: Blood-brain barrier (BBB) breakdown, as an early biomarker for vascular mild cognitive impairment (vMCI), has only been validated by a few studies. The aim of this study was to investigate whether compromised BBB integrity is involved in vMCI patients, and detect the relationship between BBB breakdown and cognitive function. BBB leakage in vMCI was explored, and the relationship between BBB leakage and cognitive function was discussed in this study. METHODS: This is a cross-sectional study involving 26 vMCI patients and 21 sex- and age-matched healthy controls. Dynamic contrast-enhanced-magnetic resonance imaging was performed for all participants, to determine BBB leakage. Leakage volume, leakage rate, and fractional blood plasma volume (Vp) in the grey and white matter were evaluated. Neuropsychological tests were used to determine cognitive function. Leakage rate, leakage volume, and Vp in different brain locations, including deep grey matter, cortical grey matter, white matter hyperintensity, and normal-appearing white matter were compared between the two groups. RESULTS: Multivariable linear regression analyses revealed that in all regions of interest, the leakage rate was significantly higher in vMCI patients relative to controls. Leakage volume in normal-appearing white matter and white matter hyperintensity were significantly higher, while Vp in normal-appearing white matter, deep grey matter, and cortical grey matter were significantly lower in vMCI patients. Moreover, Montreal Cognitive Assessment scores decreased with the increase of leakage rate in white matter hyperintensity. CONCLUSION: Increased BBB permeability was detected in vMCI patients and was related to cognitive decline, which suggested that BBB breakdown might be involved in cognitive dysfunction pathogenesis.
BACKGROUND: Blood-brain barrier (BBB) breakdown, as an early biomarker for vascular mild cognitive impairment (vMCI), has only been validated by a few studies. The aim of this study was to investigate whether compromised BBB integrity is involved in vMCI patients, and detect the relationship between BBB breakdown and cognitive function. BBB leakage in vMCI was explored, and the relationship between BBB leakage and cognitive function was discussed in this study. METHODS: This is a cross-sectional study involving 26 vMCI patients and 21 sex- and age-matched healthy controls. Dynamic contrast-enhanced-magnetic resonance imaging was performed for all participants, to determine BBB leakage. Leakage volume, leakage rate, and fractional blood plasma volume (Vp) in the grey and white matter were evaluated. Neuropsychological tests were used to determine cognitive function. Leakage rate, leakage volume, and Vp in different brain locations, including deep grey matter, cortical grey matter, white matter hyperintensity, and normal-appearing white matter were compared between the two groups. RESULTS: Multivariable linear regression analyses revealed that in all regions of interest, the leakage rate was significantly higher in vMCI patients relative to controls. Leakage volume in normal-appearing white matter and white matter hyperintensity were significantly higher, while Vp in normal-appearing white matter, deep grey matter, and cortical grey matter were significantly lower in vMCI patients. Moreover, Montreal Cognitive Assessment scores decreased with the increase of leakage rate in white matter hyperintensity. CONCLUSION: Increased BBB permeability was detected in vMCI patients and was related to cognitive decline, which suggested that BBB breakdown might be involved in cognitive dysfunction pathogenesis.
Authors: Saeid Taheri; Charles Gasparovic; Branko N Huisa; John C Adair; Elaine Edmonds; Jillian Prestopnik; Mark Grossetete; N Jon Shah; John Wills; Clifford Qualls; Gary A Rosenberg Journal: Stroke Date: 2011-06-30 Impact factor: 7.914
Authors: Sau May Wong; Jacobus F A Jansen; C Eleana Zhang; Erik I Hoff; Julie Staals; Robert J van Oostenbrugge; Walter H Backes Journal: Neurology Date: 2019-03-13 Impact factor: 9.910
Authors: C Eleana Zhang; Sau May Wong; Harm J van de Haar; Julie Staals; Jacobus F A Jansen; Cécile R L P N Jeukens; Paul A M Hofman; Robert J van Oostenbrugge; Walter H Backes Journal: Neurology Date: 2016-12-28 Impact factor: 9.910
Authors: Carla Moleiro; Sofia Madureira; Ana Verdelho; José M Ferro; Anna Poggesi; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; Michael Hennerici; John O'Brien; Leonardo Pantoni; Emilia Salvadori; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari Journal: J Clin Exp Neuropsychol Date: 2013-02-11 Impact factor: 2.475
Authors: Wiesje M van der Flier; Ingmar Skoog; Julie A Schneider; Leonardo Pantoni; Vincent Mok; Christopher L H Chen; Philip Scheltens Journal: Nat Rev Dis Primers Date: 2018-02-15 Impact factor: 52.329
Authors: Perminder Sachdev; Raj Kalaria; John O'Brien; Ingmar Skoog; Suvarna Alladi; Sandra E Black; Deborah Blacker; Dan G Blazer; Christopher Chen; Helena Chui; Mary Ganguli; Kurt Jellinger; Dilip V Jeste; Florence Pasquier; Jane Paulsen; Niels Prins; Kenneth Rockwood; Gustavo Roman; Philip Scheltens Journal: Alzheimer Dis Assoc Disord Date: 2014 Jul-Sep Impact factor: 2.703
Authors: Daniel A Nation; Melanie D Sweeney; Axel Montagne; Abhay P Sagare; Lina M D'Orazio; Maricarmen Pachicano; Farshid Sepehrband; Amy R Nelson; David P Buennagel; Michael G Harrington; Tammie L S Benzinger; Anne M Fagan; John M Ringman; Lon S Schneider; John C Morris; Helena C Chui; Meng Law; Arthur W Toga; Berislav V Zlokovic Journal: Nat Med Date: 2019-01-14 Impact factor: 53.440
Authors: Giuseppe Barisano; Axel Montagne; Kassandra Kisler; Julie A Schneider; Joanna M Wardlaw; Berislav V Zlokovic Journal: Nat Cardiovasc Res Date: 2022-02-07
Authors: Axel Montagne; Samuel R Barnes; Daniel A Nation; Kassandra Kisler; Arthur W Toga; Berislav V Zlokovic Journal: Geroscience Date: 2022-04-25 Impact factor: 7.581